查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
器官移植排斥藥物市場 - 按藥物類別（鈣調磷酸酶抑制劑、抗體、抗增殖劑）、移植類型（腎臟、肝臟、心臟）、配銷通路（醫院、零售藥房）、全球預測，2023-2032 年
市場調查報告書
商品編碼
1370638

器官移植排斥藥物市場 - 按藥物類別（鈣調磷酸酶抑制劑、抗體、抗增殖劑）、移植類型（腎臟、肝臟、心臟）、配銷通路（醫院、零售藥房）、全球預測，2023-2032 年

Organ Transplant Rejection Medication Market - By Drug Class (Calcineurin Inhibitor, Antibodies, Antiproliferative Agent), Transplant Type (Kidney, Liver, Heart), Distribution Channel (Hospital, Retail Pharmacies), Global Forecast, 2023-2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

由於慢性病發病率不斷上升以及器官移植的必要性不斷增加，預計 2023 年至 2032 年器官移植排斥藥物市場規模將以 3.2% 的年複合成長率擴大。與生活方式相關的疾病的湧入以及末期腎臟病和肝衰竭等疾病負擔的增加，導致對有效排斥藥物的需求激增。

此外，醫療保健提供者越來越重視最佳化患者的治療結果，以及不斷開發針對器官排斥的創新免疫抑制療法，這將推動市場的成長。舉個例子，2023 年 9 月，Eledon Pharmaceuticals, Inc. 透露，在第二次豬基因工程心臟移植後，其實驗性抗 CD40 抗體 tegoprubart 被用作慢性免疫抑制治療的關鍵成分對一個人。

器官移植排斥藥物產業依移植類型、配銷通路、藥品類別和地區分類。

預計抗體藥物類別的市場佔有率將在 2023 年至 2032 年間獲得顯著成長。全球器官移植手術數量的激增正在推動對有效免疫抑制療法的需求，以確保改善患者的治療結果。最近，提供增強特異性和減少不良反應的抗體已獲得廣泛關注。此外，正在進行的專注於最佳化抗體療法的研發計劃將支持該細分市場的成長。

根據配銷通路，預計到 2032 年，零售藥房領域的器官移植排斥藥物市場將實現強勁成長。廣泛的零售藥房網路及其可及性和以患者為中心的方法將極大地促進器官排斥藥物的分銷。此外，對個人化諮詢和藥物管理服務的需求不斷成長，導致器官移植排斥藥物的使用增加。

從地區來看，由於器官移植手術日益普及和慢性病發病率上升，預計到 2032 年，亞太地區器官移植排斥藥物產業將大幅成長。大規模的醫療保健投資和醫療基礎設施的進步導致對有效的免疫抑制療法以防止移植排斥的需求不斷成長。此外，大量患者的存在以及政府加強醫療保健支持性措施的實施將增強該地區的行業前景。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：器官移植排斥藥物市場洞察

  • 產業格局
  • 產業影響力
    • 成長動力
      • 由於慢性病而增加的器官移植手術
      • 器官移植和組織工程的技術進步
    • 產業陷阱與挑戰
      • 器官移植手術費用高
      • 可移植器官的可用性低
  • 成長潛力分析
  • COVID-19 影響分析
  • 監管環境
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 競爭定位矩陣
  • 戰略儀錶板

第 5 章：器官移植排斥藥物市場估計與預測：按藥物類別，2018 - 2032

  • 主要動向：依藥物類別
  • 鈣調磷酸酶抑制劑
  • 抗體
  • 抗增殖劑
  • mTOR抑制劑
  • 類固醇

第 6 章：器官移植排斥藥物市場估計與預測：按移植類型，2018 - 2032

  • 主要動向：依移植類型
  • 腎
  • 肝
  • 心
  • 肺
  • 胰臟
  • 其他移植類型

第 7 章：器官移植排斥藥物市場估計與預測：按配銷通路，2018 - 2032

  • 主要動向：按配銷通路
  • 醫院藥房
  • 零售藥局
  • 網路藥局

第 8 章：器官移植排斥藥物市場估計與預測：按地區，2018 - 2032

  • 主要動向：按地區
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 瑞士
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 中東和非洲其他地區

第 9 章：公司簡介

  • Astellas Pharma Inc.
  • Sanofi
  • Bristol-Myers Squibb Company
  • Novartis AG
  • F. Hoffmann-La Roche Ltd
  • Accord Healthcare Ltd
  • Viatris, Inc.
  • Dr. Reddy's Laboratories Ltd
  • Veloxis Pharmaceuticals A/S
  • GlaxoSmithKline plc
Product Code: 6581

Organ Transplant Rejection Medication Market size is projected to expand at 3.2% CAGR from 2023-2032 attributed to the escalating frequency of chronic diseases and the rising necessity of organ transplants. The influx of lifestyle-related ailments and the growing burden of conditions, such as end-stage renal disease and liver failure are contributing to the surging demand for effective rejection medications.

Moreover, the scaling emphasis of healthcare providers on optimizing patient outcomes along with the continuous development of innovative immunosuppressive therapies tailored to combat organ rejection will fuel the market growth. To cite an instance, in September 2023, Eledon Pharmaceuticals, Inc. revealed that tegoprubart, its experimental anti-CD40 antibody, was employed as a key component in the chronic immunosuppressive treatment after the second-ever transplant of a genetically engineered heart from a pig to a person.

The organ transplant rejection medication industry is categorized by transplant type, distribution channel, drug class, and region.

The market share from the antibodies drug class segment is anticipated to gain significant traction between 2023 and 2032. The surging number of organ transplantation procedures across the globe is driving the need for effective immunosuppressive therapies to ensure improved patient outcomes. Of late, antibodies offering enhanced specificity and reduced adverse effects have gained widespread prominence. Additionally, the ongoing R&D initiatives focused on optimizing antibody-based therapies will support the segment growth.

Based on distribution channel, the organ transplant rejection medication market from the retail pharmacies segment is anticipated to record robust growth through 2032. The widespread network of retail pharmacies coupled with their accessibility and patient-centric approach are significantly facilitating the distribution of organ rejection medications. Furthermore, the rising need for personalized counseling and medication management services is contributing to the increased uptake of organ transplant rejection medications.

Regionally, the Asia Pacific organ transplant rejection medication industry is estimated to witness substantial growth through 2032, propelled by the increasing prevalence of organ transplantation procedures and the rising incidence of chronic diseases. Massive healthcare investments and advancements in medical infrastructure are contributing to the growing demand for effective immunosuppressive therapies to prevent transplant rejection. Moreover, the presence of large patient pool and the higher implementation of supportive government initiatives to enhance healthcare access will augment the regional industry outlook.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Covid-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Secondary
      • 1.6.1.1 Paid sources
      • 1.6.1.2 Public sources
    • 1.6.2 Primary

Chapter 2 Executive Summary

  • 2.1 Organ transplant rejection medication industry 360 degree synopsis, 2018 - 2032 (USD Million)
    • 2.1.1 Business trends
    • 2.1.2 Region trends
    • 2.1.3 Drug class trends
    • 2.1.4 Transplant type trends
    • 2.1.5 Distribution channel trends

Chapter 3 Organ Transplant Rejection Medication Market Insights

  • 3.1 Industry landscape, 2018 - 2032 (USD Million)
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing organ transplant procedures due to chronic diseases
      • 3.2.1.2 Technological advancements in organ transplantation and tissue engineering
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of organ transplantation procedures
      • 3.2.2.2 Low availability of organs for transplantation
  • 3.3 Growth potential analysis
    • 3.3.1 By drug class
    • 3.3.2 By transplant type
    • 3.3.3 By distribution channel
  • 3.4 COVID-19 impact analysis
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Competitive positioning matrix, 2022
  • 4.4 Strategic dashboard, 2022

Chapter 5 Organ Transplant Rejection Medication Market Estimates and Forecast, By Drug Class, 2018 - 2032 (USD Million)

  • 5.1 Key trends, by drug class
  • 5.2 Calcineurin inhibitors
  • 5.3 Antibodies
  • 5.4 Antiproliferative agents
  • 5.5 mTOR inhibitor
  • 5.6 Steroids

Chapter 6 Organ Transplant Rejection Medication Market Estimates and Forecast, By Transplant Type, 2018 - 2032 (USD Million)

  • 6.1 Key trends, by transplant type
  • 6.2 Kidney
  • 6.3 Liver
  • 6.4 Heart
  • 6.5 Lung
  • 6.6 Pancreas
  • 6.7 Other transplant types

Chapter 7 Organ Transplant Rejection Medication Market Estimates and Forecast, By Distribution Channel, 2018 - 2032 (USD Million)

  • 7.1 Key trends, by distribution channel
  • 7.2 Hospital pharmacies
  • 7.3 Retail pharmacies
  • 7.4 Online pharmacies

Chapter 8 Organ Transplant Rejection Medication Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

  • 8.1 Key trends, by region
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Switzerland
    • 8.3.7 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Rest of Latin America
  • 8.6 Middle East & Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 Rest of Middle East & Africa

Chapter 9 Company Profiles

  • 9.1 Astellas Pharma Inc.
  • 9.2 Sanofi
  • 9.3 Bristol-Myers Squibb Company
  • 9.4 Novartis AG
  • 9.5 F. Hoffmann-La Roche Ltd
  • 9.6 Accord Healthcare Ltd
  • 9.7 Viatris, Inc.
  • 9.8 Dr. Reddy's Laboratories Ltd
  • 9.9 Veloxis Pharmaceuticals A/S
  • 9.10 GlaxoSmithKline plc

Data Tables

  • TABLE 1 Product mapping
  • TABLE 2 Market revenue, by drug class (2022)
  • TABLE 3 Market revenue, by transplant type (2022)
  • TABLE 4 Market revenue, by distribution channel (2022)
  • TABLE 5 Market share, by region (2022)
  • TABLE 6 Global organ transplant rejection medicine market size, by region, 2018 - 2022 (USD Million)
  • TABLE 7 Global organ transplant rejection medicine market size, by region, 2023 - 2032 (USD Million)
  • TABLE 8 Global organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 9 Global organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 10 Global organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 11 Global organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 12 Global organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 13 Global organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 14 Industry impact forces
  • TABLE 15 Competitive benchmarking of major market players
  • TABLE 16 Competitive positioning matrix: Classification criteria
  • TABLE 17 Strategic outlook matrix: Classification criteria
  • TABLE 18 Calcineurin inhibitors market size, by region, 2018 - 2022 (USD Million)
  • TABLE 19 Calcineurin inhibitors market size, by region, 2023 - 2032 (USD Million)
  • TABLE 20 Antibodies market size, by region, 2018 - 2022 (USD Million)
  • TABLE 21 Antibodies market size, by region, 2023 - 2032 (USD Million)
  • TABLE 22 Antiproliferative agents market size, by region, 2018 - 2022 (USD Million)
  • TABLE 23 Antiproliferative agents market size, by region, 2023 - 2032 (USD Million)
  • TABLE 24 mTOR inhibitor market size, by region, 2018 - 2022 (USD Million)
  • TABLE 25 mTOR inhibitor market size, by region, 2023 - 2032 (USD Million)
  • TABLE 26 Steroids market size, by region, 2018 - 2022 (USD Million)
  • TABLE 27 Steroids market size, by region, 2023 - 2032 (USD Million)
  • TABLE 28 Kidney market size, by region, 2018 - 2022 (USD Million)
  • TABLE 29 Kidney market size, by region, 2023 - 2032 (USD Million)
  • TABLE 30 Liver market size, by region, 2018 - 2022 (USD Million)
  • TABLE 31 Liver market size, by region, 2023 - 2032 (USD Million)
  • TABLE 32 Heart market size, by region, 2018 - 2022 (USD Million)
  • TABLE 33 Heart market size, by region, 2023 - 2032 (USD Million)
  • TABLE 34 Lung market size, by region, 2018 - 2022 (USD Million)
  • TABLE 35 Lung market size, by region, 2023 - 2032 (USD Million)
  • TABLE 36 Pancreas market size, by region, 2018 - 2022 (USD Million)
  • TABLE 37 Pancreas market size, by region, 2023 - 2032 (USD Million)
  • TABLE 38 Other transplant types market size, by region, 2018 - 2022 (USD Million)
  • TABLE 39 Other transplant types market size, by region, 2023 - 2032 (USD Million)
  • TABLE 40 Hospital pharmacies market size, by region, 2018 - 2022 (USD Million)
  • TABLE 41 Hospital pharmacies market size, by region, 2023 - 2032 (USD Million)
  • TABLE 42 Retail pharmacies market size, by region, 2018 - 2022 (USD Million)
  • TABLE 43 Retail pharmacies market size, by region, 2023 - 2032 (USD Million)
  • TABLE 44 Online pharmacies market size, by region, 2018 - 2022 (USD Million)
  • TABLE 45 Online pharmacies market size, by region, 2023 - 2032 (USD Million)
  • TABLE 46 North America organ transplant rejection medicine market size, by country, 2018 - 2022 (USD Million)
  • TABLE 47 North America organ transplant rejection medicine market size, by country, 2023 - 2032 (USD Million)
  • TABLE 48 North America organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 49 North America organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 50 North America organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 51 North America organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 52 North America organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 53 North America organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 54 U.S. organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 55 U.S. organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 56 U.S. organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 57 U.S. organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 58 U.S. organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 59 U.S. organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 60 Canada organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 61 Canada organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 62 Canada organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 63 Canada organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 64 Canada organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 65 Canada organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 66 Europe organ transplant rejection medicine market size, by country, 2018 - 2022 (USD Million)
  • TABLE 67 Europe organ transplant rejection medicine market size, by country, 2023 - 2032 (USD Million)
  • TABLE 68 Europe organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 69 Europe organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 70 Europe organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 71 Europe organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 72 Europe organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 73 Europe organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 74 Germany organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 75 Germany organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 76 Germany organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 77 Germany organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 78 Germany organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 79 Germany organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 80 UK organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 81 UK organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 82 UK organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 83 UK organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 84 UK organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 85 UK organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 86 France organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 87 France organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 88 France organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 89 France organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 90 France organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 91 France organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 92 Spain organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 93 Spain organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 94 Spain organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 95 Spain organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 96 Spain organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 97 Spain organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 98 Italy organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 99 Italy organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 100 Italy organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 101 Italy organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 102 Italy organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 103 Italy organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 104 Switzerland organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 105 Switzerland organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 106 Switzerland organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 107 Switzerland organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 108 Switzerland organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 109 Switzerland organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 110 Rest of Europe organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 111 Rest of Europe organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 112 Rest of Europe organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 113 Rest of Europe organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 114 Rest of Europe organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 115 Rest of Europe organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 116 Asia Pacific organ transplant rejection medicine market size, by country, 2018 - 2022 (USD Million)
  • TABLE 117 Asia Pacific organ transplant rejection medicine market size, by country, 2023 - 2032 (USD Million)
  • TABLE 118 Asia Pacific organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 119 Asia Pacific organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 120 Asia Pacific organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 121 Asia Pacific organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 122 Asia Pacific organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 123 Asia Pacific organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 124 China organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 125 China organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 126 China organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 127 China organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 128 China organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 129 China organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 130 Japan organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 131 Japan organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 132 Japan organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 133 Japan organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 134 Japan organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 135 Japan organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 136 India organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 137 India organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 138 India organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 139 India organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 140 India organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 141 India organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 142 Australia organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 143 Australia organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 144 Australia organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 145 Australia organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 146 Australia organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 147 Australia organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 148 South Korea organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 149 South Korea organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 150 South Korea organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 151 South Korea organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 152 South Korea organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 153 South Korea organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 154 Rest of Asia Pacific organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 155 Rest of Asia Pacific organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 156 Rest of Asia Pacific organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 157 Rest of Asia Pacific organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 158 Rest of Asia Pacific organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 159 Rest of Asia Pacific organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 160 Latin America organ transplant rejection medicine market size, by country, 2018 - 2022 (USD Million)
  • TABLE 161 Latin America organ transplant rejection medicine market size, by country, 2023 - 2032 (USD Million)
  • TABLE 162 Latin America organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 163 Latin America organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 164 Latin America organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 165 Latin America organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 166 Latin America organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 167 Latin America organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 168 Brazil organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 169 Brazil organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 170 Brazil organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 171 Brazil organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 172 Brazil organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 173 Brazil organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 174 Mexico organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 175 Mexico organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 176 Mexico organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 177 Mexico organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 178 Mexico organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 179 Mexico organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 180 Rest of Latin America organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 181 Rest of Latin America organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 182 Rest of Latin America organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 183 Rest of Latin America organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 184 Rest of Latin America organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 185 Rest of Latin America organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 186 Middle East & Africa organ transplant rejection medicine market size, by country, 2018 - 2022 (USD Million)
  • TABLE 187 Middle East & Africa organ transplant rejection medicine market size, by country, 2023 - 2032 (USD Million)
  • TABLE 188 Middle East & Africa organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 189 Middle East & Africa organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 190 Middle East & Africa organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 191 Middle East & Africa organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 192 Middle East & Africa organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 193 Middle East & Africa organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 194 South Africa organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 195 South Africa organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 196 South Africa organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 197 South Africa organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 198 South Africa organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 199 South Africa organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 200 Saudi Arabia organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 201 Saudi Arabia organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 202 Saudi Arabia organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 203 Saudi Arabia organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 204 Saudi Arabia organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 205 Saudi Arabia organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 206 Rest of Middle East & Africa organ transplant rejection medicine market size, by drug class, 2018 - 2022 (USD Million)
  • TABLE 207 Rest of Middle East & Africa organ transplant rejection medicine market size, by drug class, 2023 - 2032 (USD Million)
  • TABLE 208 Rest of Middle East & Africa organ transplant rejection medicine market size, by transplant type, 2018 - 2022 (USD Million)
  • TABLE 209 Rest of Middle East & Africa organ transplant rejection medicine market size, by transplant type, 2023 - 2032 (USD Million)
  • TABLE 210 Rest of Middle East & Africa organ transplant rejection medicine market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 211 Rest of Middle East & Africa organ transplant rejection medicine market size, by distribution channel, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: Critical research elements
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Organ transplant rejection medicine industry 36 degree synopsis, 2018 - 2032
  • FIG 7 Growth potential analysis, by drug class
  • FIG 8 Growth potential analysis, by transplant type
  • FIG 9 Growth potential analysis, by distribution channel
  • FIG 10 Porter's analysis
  • FIG 11 PESTEL analysis
  • FIG 12 Company matrix analysis, 2022
  • FIG 13 Global company market share analysis, 2022
  • FIG 14 Competitive positioning matrix, 2022
  • FIG 15 Strategic dashboard, 2022